Skip to main content

Articles

Page 19 of 26

  1. Significant renal mass reduction induced by 5/6 subtotal nephrectomy (Nx) is associated with a chain of events that culminates in hypertension and chronic kidney disease (CKD). Numerous studies have provided e...

    Authors: Basma Ismail, Robert A. deKemp, Tayebeh Hadizad, Kumiko Mackasey, Rob S. Beanlands and Jean N. DaSilva
    Citation: EJNMMI Research 2016 6:55
  2. Organic cation transporters (OCTs) in the renal proximal tubule are important for the excretion of both exo- and endogenous compounds, and chronic kidney disease (CKD) alter the expression of OCT. Metformin is...

    Authors: Lea Pedersen, Jonas Brorson Jensen, Lise Wogensen, Ole Lajord Munk, Niels Jessen, Jørgen Frøkiær and Steen Jakobsen
    Citation: EJNMMI Research 2016 6:54
  3. We have demonstrated recently that the tumor-to-blood standard uptake ratio (SUR) is superior to tumor standardized uptake value (SUV) as a surrogate of the metabolic uptake rate K m of...

    Authors: Frank Hofheinz, Jörg van den Hoff, Ingo G. Steffen, Alexandr Lougovski, Kilian Ego, Holger Amthauer and Ivayla Apostolova
    Citation: EJNMMI Research 2016 6:53
  4. Cardiac sarcoidosis (CS) is a potentially fatal condition lacking a single test with acceptable diagnostic accuracy. 18F-FDG PET/CT has emerged as a promising imaging modality, but is challenged by physiological ...

    Authors: Lars C. Gormsen, Ate Haraldsen, Stine Kramer, Andre H. Dias, Won Yong Kim and Per Borghammer
    Citation: EJNMMI Research 2016 6:52
  5. Authors: Anu Autio, Helena Virtanen, Tuula Tolvanen, Heidi Liljenbäck, Vesa Oikonen, Tiina Saanijoki, Riikka Siitonen, Meeri Käkelä, Andrea Schüssele, Mika Teräs and Anne Roivainen
    Citation: EJNMMI Research 2016 6:51

    The original article was published in EJNMMI Research 2015 5:40

  6. 177Lu is used in peptide receptor radionuclide therapies for the treatment of neuroendocrine tumors. Based on the recent literature, SST2 antagonists are superior to agonists in tumor ...

    Authors: Seval Beykan, Jan S. Dam, Uta Eberlein, Jens Kaufmann, Benedict Kjærgaard, Lars Jødal, Hakim Bouterfa, Romain Bejot, Michael Lassmann and Svend Borup Jensen
    Citation: EJNMMI Research 2016 6:50
  7. Human T lymphocytes infiltrating tissues in autoimmune diseases are known to express somatostatin receptors amongst other activation markers. In this study, we evaluated whether somatostatin receptor scintigra...

    Authors: L. K. Anzola-Fuentes, M. Chianelli, F. Galli, A. W. J. M. Glaudemans, L. Martin Martin, V. Todino, A. Migliore and A. Signore
    Citation: EJNMMI Research 2016 6:49
  8. DNA damage occurs as a consequence of both direct and indirect effects of ionizing radiation. The severity of DNA damage depends on the physical characteristics of the radiation quality, e.g., the linear energ...

    Authors: Roswitha Runge, Liane Oehme, Jörg Kotzerke and Robert Freudenberg
    Citation: EJNMMI Research 2016 6:48
  9. In PET/MRI, linear photon attenuation coefficients for attenuation correction (AC) cannot be directly derived, and cortical bone is, so far, usually not considered. This results in an underestimation of the av...

    Authors: P. Werner, M. Rullmann, A. Bresch, S. Tiepolt, T. Jochimsen, D. Lobsien, M. L. Schroeter, O. Sabri and H. Barthel
    Citation: EJNMMI Research 2016 6:47
  10. Bone disease in multiple myeloma is characterized by reduced bone formation. The gold standard of bone formation is the mineral apposition rate (MAR), an invasive technique reflecting bone formation at a singl...

    Authors: J. C. Regelink, P. G. Raijmakers, N. Bravenboer, R. Milek, N. J. Hoetjes, A. M. de Kreuk, M. van Duin, M. J. Wondergem, P. Lips, P. Sonneveld, J. M. Zijlstra and S. Zweegman
    Citation: EJNMMI Research 2016 6:46
  11. It is unclear how to predict which patients will respond to Y-90 radiosynoviorthesis. The aim of this study is to correlate clinical outcomes following Y-90 radiosynoviorthesis with bremsstrahlung and Y-90 PET...

    Authors: Thomas W. Barber, Martin H. Cherk, Anne Powell, Kenneth S. K. Yap, Baki Billah and Victor Kalff
    Citation: EJNMMI Research 2016 6:45
  12. We aimed to determine the accuracy of laser Doppler perfusion imaging (LDPI) in an animal model for hind limb ischemia.

    Authors: Geert Hendrikx, Mark H. Vries, Matthias Bauwens, Marijke De Saint-Hubert, Allard Wagenaar, Joël Guillaume, Levinia Boonen, Mark J. Post and Felix M. Mottaghy
    Citation: EJNMMI Research 2016 6:44
  13. Pulmonary perfusion is not spatially homogeneously distributed, and its variations could be of diagnostic value in lung vascular disease. PulmoBind is a ligand of the adrenomedullin receptor densely expressed ...

    Authors: Xavier Levac, François Harel, Vincent Finnerty, Quang T. Nguyen, Myriam Letourneau, Sophie Marcil, Alain Fournier and Jocelyn Dupuis
    Citation: EJNMMI Research 2016 6:43
  14. The purposes of this study are to evaluate the prognostic value of posttreatment 18F-FDG PET/CT in predicting the survival of patients with ovarian carcinoma and to determine incremental value of combining posttr...

    Authors: Linda C. Chu, Hua-Ling Tsai, Hao Wang, John Crandall, Mehrbod S. Javadi and Richard L. Wahl
    Citation: EJNMMI Research 2016 6:42
  15. Accelerated clearance of 99mtechnetium-sestamibi (MIBI) has been observed after reperfusion therapy in patients with acute coronary syndrome (ACS), but the mechanisms have not been fully investigated. MIBI retent...

    Authors: Atsuro Masuda, Keiichiro Yoshinaga, Masanao Naya, Osamu Manabe, Satoshi Yamada, Hiroyuki Iwano, Tatsuya Okada, Chietsugu Katoh, Yasuchika Takeishi, Hiroyuki Tsutsui and Nagara Tamaki
    Citation: EJNMMI Research 2016 6:41
  16. Prostate-specific membrane antigen (PSMA) is frequently overexpressed and upregulated in prostate cancer. To date, various 18F- and 68Ga-labeled urea-based radiotracers for PET imaging of PSMA have been developed...

    Authors: Vincent Bouvet, Melinda Wuest, Hans-Soenke Jans, Nancy Janzen, Afaf R. Genady, John F. Valliant, Francois Benard and Frank Wuest
    Citation: EJNMMI Research 2016 6:40
  17. Studies on imaging of differentiated thyroid cancer (DTC) using 124I often require a multicenter approach, as the prevalence of DTC is low. Calibration of participating scanners is required to obtain comparable q...

    Authors: Jakob W. Kist, Manfred van der Vlies, Otto S. Hoekstra, Henri N. J. M. Greuter, Bart de Keizer, Marcel P. M. Stokkel, Wouter V. Vogel, Marc C. Huisman and Arthur van Lingen
    Citation: EJNMMI Research 2016 6:39
  18. Facilitation of the differentiation of the stem cells toward neuronal lineage is crucial for enhancing the differentiation efficacy of grafted stem cells for the possible treatment of neurodegenerative disorde...

    Authors: Jaeho Jang, Song Lee, Hyun Jeong Oh, Yoori Choi, Jae Hyouk Choi, Do Won Hwang and Dong Soo Lee
    Citation: EJNMMI Research 2016 6:38
  19. Cyclooxygenase-2 (COX-2) is the inducible isoform of the cyclooxygenase enzyme family. COX-2 is involved in tumor development and progression, and frequent overexpression of COX-2 in a variety of human cancers...

    Authors: Ole Tietz, Melinda Wuest, Alison Marshall, Darryl Glubrecht, Ingrit Hamann, Monica Wang, Cody Bergman, Jenilee D. Way and Frank Wuest
    Citation: EJNMMI Research 2016 6:37
  20. The overexpression of the chemokine receptor 4 (CXCR4) in different epithelial, mesenchymal, and hematopoietic cancers makes CXCR4 an attractive diagnostic and therapeutic target. However, targeting the CXCR4 ...

    Authors: Andreas Poschenrieder, Margret Schottelius, Markus Schwaiger, Horst Kessler and Hans-Jürgen Wester
    Citation: EJNMMI Research 2016 6:36
  21. Terbium has attracted the attention of researchers and physicians due to the existence of four medically interesting radionuclides, potentially useful for SPECT and PET imaging, as well as for α- and β−-radionucl...

    Authors: Cristina Müller, Christiaan Vermeulen, Karl Johnston, Ulli Köster, Raffaella Schmid, Andreas Türler and Nicholas P. van der Meulen
    Citation: EJNMMI Research 2016 6:35
  22. [18F]BF4 −, the first 18F-labelled PET imaging agent for the sodium/iodide symporter (NIS), was produced by isotopic exchange yielding a product with limited specific activity (SA, ca. ...

    Authors: Alex Khoshnevisan, Maite Jauregui-Osoro, Karen Shaw, Julia Baguña Torres, Jennifer D. Young, Nisha K. Ramakrishnan, Alex Jackson, Gareth E. Smith, Antony D. Gee and Philip J. Blower
    Citation: EJNMMI Research 2016 6:34
  23. Hypoxia is associated with resistance to chemotherapy and radiotherapy and is randomly distributed within malignancies. Characterization of changes in intratumoral hypoxic regions is possible with specially de...

    Authors: Gerald S. M. A. Kerner, Vikram R. Bollineni, Thijo J. N. Hiltermann, Nanna M. Sijtsema, Alexander Fischer, Alphons H. H. Bongaerts, Jan Pruim and Harry J. M. Groen
    Citation: EJNMMI Research 2016 6:33
  24. A1 68Ga-PSMA PET/CT in staging and restaging of Prostate Cancer Patients: comparative study with 18F-Choline PET/CT

    Authors: W Langsteger, A Rezaee, W Loidl, HS Geinitz, F Fitz, M Steinmair, G Broinger, L Pallwien-Prettner, M Beheshti, L Imamovic, M Beheshti, G Rendl, D Hackl, O Tsybrovsky, M Steinmair, K Emmanuel…
    Citation: EJNMMI Research 2016 6(Suppl 1):32

    This article is part of a Supplement: Volume 6 Supplement 1

  25. The melanin-concentrating hormone receptor 1 (MCHR1), which is highly expressed in the lateral hypothalamus, plays a key role in energy homeostasis, obesity and other endocrine diseases. Hence, there is a majo...

    Authors: Cécile Philippe, Daniela Haeusler, Thomas Scherer, Clemens Fürnsinn, Markus Zeilinger, Wolfgang Wadsak, Karem Shanab, Helmut Spreitzer, Marcus Hacker and Markus Mitterhauser
    Citation: EJNMMI Research 2016 6:31
  26. Peptide receptor radionuclide therapy (PRRT) plays an important role in the treatment of neuroendocrine tumors (NET). Pre-therapeutic dosimetry using the area under the measured time-activity curve (AUC) is im...

    Authors: Christian Maaß, Jan Philipp Sachs, Deni Hardiansyah, Felix M. Mottaghy, Peter Kletting and Gerhard Glatting
    Citation: EJNMMI Research 2016 6:30
  27. αVβ3-integrin is expressed by activated endothelial cells and macrophages in atherosclerotic plaques and may represent a valuable marker of high-risk plaques. We evaluated 99mTc-maraciclatide, an integrin-specifi...

    Authors: David Vancraeynest, Véronique Roelants, Caroline Bouzin, François-Xavier Hanin, Stephan Walrand, Vanesa Bol, Anne Bol, Anne-Catherine Pouleur, Agnès Pasquet, Bernhard Gerber, Philippe Lesnik, Thierry Huby, François Jamar and Jean-Louis Vanoverschelde
    Citation: EJNMMI Research 2016 6:29
  28. Absorbed dose estimates for pediatric patients require pharmacokinetics that are, to the extent possible, age-specific. Such age-specific pharmacokinetic data are lacking for many of the diagnostic agents typi...

    Authors: Kitiwat Khamwan, Donika Plyku, Shannon E. O’Reilly, Alison Goodkind, Xinhua Cao, Frederic H. Fahey, S. Ted Treves, Wesley E. Bolch and George Sgouros
    Citation: EJNMMI Research 2016 6:28
  29. Prostate cancer ranks as the second most lethal malignancy in the Western world. Previous targeting of prostate-specific antigen and human kallikrein-related peptidase 2, two related enzymes abundantly express...

    Authors: O. Vilhelmsson Timmermand, E. Larsson, D. Ulmert, T. A. Tran and SE. Strand
    Citation: EJNMMI Research 2016 6:27
  30. The aim of the study was to explore Fc mutations of a humanised anti-Lewis-Y antibody (IgG1) hu3S193 as a strategy to improve therapeutic ratios for therapeutic payload delivery.

    Authors: Ingrid J. G. Burvenich, Fook-Thean Lee, Graeme J. O’Keefe, Dahna Makris, Diana Cao, Sylvia Gong, Angela Rigopoulos, Laura C. Allan, Martin W. Brechbiel, Zhanqi Liu, Paul A. Ramsland and Andrew M. Scott
    Citation: EJNMMI Research 2016 6:26
  31. Gene therapy has been hampered by low expression upon in vivo delivery. Using a somatostatin receptor type 2 (SSTR2)-based reporter, we assessed whether angiotensin II (AII) can improve gene expression by aden...

    Authors: Sheela P. Singh, Murali K. Ravoori, Katherine A. Dixon, Lin Han, Sanjay Gupta, Rajesh Uthamanthil, Kenneth C. Wright and Vikas Kundra
    Citation: EJNMMI Research 2016 6:25
  32. Quantitative in vivo imaging of tau pathologies potentially improves diagnostic accuracy of neurodegenerative tauopathies and would facilitate evaluation of disease-modifying drugs targeting tau lesions in the...

    Authors: Yasuyuki Kimura, Hironobu Endo, Masanori Ichise, Hitoshi Shimada, Chie Seki, Yoko Ikoma, Hitoshi Shinotoh, Makiko Yamada, Makoto Higuchi, Ming-Rong Zhang and Tetsuya Suhara
    Citation: EJNMMI Research 2016 6:24
  33. Having performed analytical validation studies, we are now assessing the clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant prostate cancer (mCRPC). In the pres...

    Authors: Aseem Anand, Michael J. Morris, Steven M. Larson, David Minarik, Andreas Josefsson, John T. Helgstrand, Peter S. Oturai, Lars Edenbrandt, Martin Andreas Røder and Anders Bjartell
    Citation: EJNMMI Research 2016 6:23
  34. Automated protocols for measuring and dispensing solutions containing radioisotopes are essential not only for providing a safe environment for radiation workers but also to ensure accuracy of dispensed radioa...

    Authors: Alex A. Dooraghi, Lewis Carroll, Jeffrey Collins, R. Michael van Dam and Arion F. Chatziioannou
    Citation: EJNMMI Research 2016 6:22
  35. This study is an assessment of the impact of acquisition times on SUV with [18F]FDG-PET/CT on healthy livers (reference organ with stable uptake over time) and on tumors.

    Authors: Avigaëlle Sher, Franck Lacoeuille, Pacôme Fosse, Laurent Vervueren, Aurélie Cahouet-Vannier, Djamel Dabli, Francis Bouchet and Olivier Couturier
    Citation: EJNMMI Research 2016 6:21
  36. The standardized uptake value (SUV) is the nearly exclusive means for quantitative evaluation of clinical [18F-]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) whole body investigations. Howeve...

    Authors: Frank Hofheinz, Rebecca Bütof, Ivayla Apostolova, Klaus Zöphel, Ingo G. Steffen, Holger Amthauer, Jörg Kotzerke, Michael Baumann and Jörg van den Hoff
    Citation: EJNMMI Research 2016 6:19
  37. α3β1 integrin is overexpressed in several types of human cancer and is associated with poor prognosis, metastasis, and resistance to cancer treatment. We previously identified a cyclic peptide ligand LXY1 that...

    Authors: Wenwu Xiao, Tianhong Li, Fernanda C. Bononi, Diana Lac, Ivy A. Kekessie, Yanlei Liu, Eduardo Sanchez, Anisha Mazloom, Ai-hong Ma, Jia Lin, Jimmy Tran, Kevin Yang, Kit S. Lam and Ruiwu Liu
    Citation: EJNMMI Research 2016 6:18
  38. Overexpression of the gastrin-releasing peptide receptor (GRP-R) has been documented in several human neoplasms such as breast, prostate, and ovarian cancer. There is growing interest in developing radiolabele...

    Authors: Antonella Accardo, Filippo Galli, Rosalba Mansi, Luigi Del Pozzo, Michela Aurilio, Anna Morisco, Paola Ringhieri, Alberto Signore, Giancarlo Morelli and Luigi Aloj
    Citation: EJNMMI Research 2016 6:17
  39. In targeted radionuclide therapy (TRT), accurate quantification using SPECT/CT images is important for optimizing radiation dose delivered to both the tumour and healthy tissue. Quantitative SPECT images are r...

    Authors: Eero Hippeläinen, Mikko Tenhunen, Hanna Mäenpää and Antti Sohlberg
    Citation: EJNMMI Research 2016 6:16
  40. We have recently shown that treatment of mice with the neutral endopeptidase (NEP) inhibitor phosphoramidon (PA) improves the bioavailability and tumor uptake of biodegradable radiopeptides. For the truncated ...

    Authors: Aikaterini Kaloudi, Berthold A. Nock, Emmanouil Lymperis, Roelf Valkema, Eric P. Krenning, Marion de Jong and Theodosia Maina
    Citation: EJNMMI Research 2016 6:15
  41. Optical molecular imaging is an emerging novel technology with applications in the diagnosis of cancer and assistance in image-guided surgery. A high tumour-to-background (T/B) ratio is crucial for successful ...

    Authors: Marta M. Kijanka, Aram S. A. van Brussel, Elsken van der Wall, Willem P. T. M. Mali, Paul J. van Diest, Paul M. P. van Bergen en Henegouwen and Sabrina Oliveira
    Citation: EJNMMI Research 2016 6:14
  42. The radiolanthanide 161Tb has, in recent years, attracted increasing interest due to its favorable characteristics for medical application. 161Tb exhibits similar properties to the widely-used therapeutic radionu...

    Authors: Stephanie Haller, Giovanni Pellegrini, Christiaan Vermeulen, Nicholas P. van der Meulen, Ulli Köster, Peter Bernhardt, Roger Schibli and Cristina Müller
    Citation: EJNMMI Research 2016 6:13
  43. Single photon emission computed tomography (SPECT) is an indispensable tool in the determination of the in vivo fate of polymeric micelles. However, for this purpose, the micelles need to be radiolabeled, and ...

    Authors: Adrianus C. Laan, Costanza Santini, Laurence Jennings, Marion de Jong, Monique R. Bernsen and Antonia G. Denkova
    Citation: EJNMMI Research 2016 6:12
  44. Histamine H3 receptor (H3R) is a potential therapeutic target of sleep- and cognition-related disorders. The purpose of the present study is to develop a novel positron emission tomography (PET) ligand for H3Rs f...

    Authors: Kazumi Koga, Jun Maeda, Masaki Tokunaga, Masayuki Hanyu, Kazunori Kawamura, Mari Ohmichi, Toshio Nakamura, Yuji Nagai, Chie Seki, Yasuyuki Kimura, Takafumi Minamimoto, Ming-Rong Zhang, Toshimitsu Fukumura, Tetsuya Suhara and Makoto Higuchi
    Citation: EJNMMI Research 2016 6:11
  45. In non-small cell lung cancer (NSCLC) patients off erlotinib therapy, positron emission tomography (PET) using [11C]erlotinib distinguished epidermal growth factor receptor (EGFR) mutations from wild-type EGFR. H...

    Authors: Idris Bahce, Maqsood Yaqub, Hanane Errami, Robert C. Schuit, Patrick Schober, Erik Thunnissen, Albert D. Windhorst, Adriaan A. Lammertsma, Egbert F. Smit and N. Harry Hendrikse
    Citation: EJNMMI Research 2016 6:10
  46. In patients with small hearts, the Quantitative Gated single-photon emission computed tomography (SPECT) (QGS) program frequently underestimates the left ventricular (LV) end-systolic volume (ESV) and overesti...

    Authors: Chisato Kondo, Eri Watanabe, Mitsuru Momose, Kenji Fukushima, Koichiro Abe, Nobuhisa Hagiwara and Shuji Sakai
    Citation: EJNMMI Research 2016 6:9
  47. We applied a non-linear immunokinetic model to quantitatively compare absolute antibody uptake and turnover in subcutaneous LNCaP human prostate cancer (PCa) xenografts of two radiolabeled forms of the humaniz...

    Authors: Edward K. Fung, Sarah M. Cheal, Shoaib B. Fareedy, Blesida Punzalan, Volkan Beylergil, Jawaria Amir, Sandhya Chalasani, Wolfgang A. Weber, Daniel E. Spratt, Darren R. Veach, Neil H. Bander, Steven M. Larson, Pat B. Zanzonico and Joseph R. Osborne
    Citation: EJNMMI Research 2016 6:7
  48. Targeted alpha therapy has been postulated to have great potential for the treatment of small clusters of tumour cells as well as small metastases. 213Bismuth, an α-emitter with a half-life of 46 min, has shown t...

    Authors: Ho Sze Chan, Mark W. Konijnenberg, Erik de Blois, Stuart Koelewijn, Richard P. Baum, Alfred Morgenstern, Frank Bruchertseifer, Wouter A. Breeman and Marion de Jong
    Citation: EJNMMI Research 2016 6:6

EANM'24 - Future Congress!

EANM'24 banner horizontal

Future Congress

37th Annual Congress of the European Association of Nuclear Medicine

October 19 – 23, 2024
Hamburg, Germany


CCH – Congress Center Hamburg
Congressplatz 1
20355 Hamburg, Germany
URL: https://www.cch.de/en/

The EJNMMI Journal Family and EANM Springer Award

New Content Item

EJNMMI is part of the EJNMMI Journal Family. Highlights of our featured content and the latest developments from the EJNMMI group of journals can be found on the EJNMMI Journal Family webpage. There you find details about the annual EANM Springer Prize.


Do you want to publish your paper open access?

Details of the OpenChoice option in EJNMMI are available in the submission guidelines.

If your institution has a Read and Publish (Springer Compact) agreement, you may publish your article open access at no cost to you. In addition, you can enjoy full access to all Springer subscription journal content.

Please check the agreement details by participating country here.